Notice of Intent to Publish Funding Opportunity Announcements for Phase 2 of the U.S.-South Africa Program for Collaborative Biomedical Research (R01 and U01, Clinical Trial Optional)

Funding Agency:
National Institutes of Health

 

The National Institute of Allergy and Infectious Diseases (NIAID) is issuing this Notice to promote new initiatives that will solicit applications to support research under Phase 2 of the U.S.-South Africa Program for Collaborative Biomedical Research. The intent of this program is to foster, stimulate, and/or expand basic, translational, behavioral and applied research that will advance scientific discovery and engage U.S. and South African researchers working collaboratively in the areas of HIV/AIDS, HIV/AIDS-associated malignancies, and other infectious diseases. These FOAs will utilize the R01 and U01 activity codes, and U.S. and South African investigators working in partnership will prepare and submit a single joint application. This notice is provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications.  These FOAs are expected to be published in March 2019 with an expected application due date in July 2019.

Estimated Synopsis Post Date: Mar 06, 2019
Estimated Application Due Date: Jul 26, 2019  

Eligibility

Faculty

Category

International Opportunities
Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational
Social Sciences

External Deadline

July 26, 2019